Literature DB >> 25722732

Lupus Nephritis: Animal Modeling of a Complex Disease Syndrome Pathology.

Tracy L McGaha1, Michael P Madaio2.   

Abstract

Nephritis as a result of autoimmunity is a common morbidity associated with Systemic Lupus Erythematosus (SLE). There is substantial clinical and industry interest in medicinal intervention in the SLE nephritic process; however, clinical trials to specifically treat lupus nephritis have not resulted in complete and sustained remission in all patients. Multiple mouse models have been used to investigate the pathologic interactions between autoimmune reactivity and SLE pathology. While several models bear a remarkable similarity to SLE-driven nephritis, there are limitations for each that can make the task of choosing the appropriate model for a particular aspect of SLE pathology challenging. This is not surprising given the variable and diverse nature of human disease. In many respects, features among murine strains mimic some (but never all) of the autoimmune and pathologic features of lupus patients. Although the diversity often limits universal conclusions relevant to pathogenesis, they provide insights into the complex process that result in phenotypic manifestations of nephritis. Thus nephritis represents a microcosm of systemic disease, with variable lesions and clinical features. In this review, we discuss some of the most commonly used models of lupus nephritis (LN) and immune-mediated glomerular damage examining their relative strengths and weaknesses, which may provide insight in the human condition.

Entities:  

Year:  2014        PMID: 25722732      PMCID: PMC4337231          DOI: 10.1016/j.ddmod.2014.08.002

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN: 1740-6757


  44 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.

Authors:  H Watanabe; G Garnier; A Circolo; R A Wetsel; P Ruiz; V M Holers; S A Boackle; H R Colten; G S Gilkeson
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

3.  Polygenic control of susceptibility to murine systemic lupus erythematosus.

Authors:  L Morel; U H Rudofsky; J A Longmate; J Schiffenbauer; E K Wakeland
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

4.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

5.  Complement factor H deficiency accelerates development of lupus nephritis.

Authors:  Lihua Bao; Mark Haas; Richard J Quigg
Journal:  J Am Soc Nephrol       Date:  2010-12-09       Impact factor: 10.121

6.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.

Authors:  Onkar Kulkarni; Rahul D Pawar; Werner Purschke; Dirk Eulberg; Norma Selve; Klaus Buchner; Volha Ninichuk; Stephan Segerer; Volker Vielhauer; Sven Klussmann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2007-07-11       Impact factor: 10.121

9.  Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice.

Authors:  Silvia Bolland; Young-Sun Yim; Katalin Tus; Edward K Wakeland; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  9 in total

1.  Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus.

Authors:  Jin-Young Choi; Abhinav Seth; Michael Kashgarian; Sonia Terrillon; Emma Fung; Lili Huang; Li Chun Wang; Joe Craft
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 2.  A systems approach to renal inflammation in SLE.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  Clin Immunol       Date:  2016-08-14       Impact factor: 3.969

Review 3.  Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.

Authors:  Tracy L McGaha; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

4.  Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis.

Authors:  Rebecca Abraham; Madeleine S Durkee; Junting Ai; Margaret Veselits; Gabriel Casella; Yuta Asano; Anthony Chang; Kichul Ko; Charles Oshinsky; Emily Peninger; Maryellen L Giger; Marcus R Clark
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

Review 5.  Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis.

Authors:  Alexandra Linke; Gisa Tiegs; Katrin Neumann
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

Review 6.  Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.

Authors:  Susan Yung; Desmond Yh Yap; Tak Mao Chan
Journal:  F1000Res       Date:  2017-06-13

Review 7.  Kidney disease models: tools to identify mechanisms and potential therapeutic targets.

Authors:  Yin-Wu Bao; Yuan Yuan; Jiang-Hua Chen; Wei-Qiang Lin
Journal:  Zool Res       Date:  2018-03-18

Review 8.  Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease.

Authors:  Jiali Wang; Yongda Lin; Xiutian Chen; Yiping Liu; Tianbiao Zhou
Journal:  Front Cell Dev Biol       Date:  2022-10-04

Review 9.  Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.

Authors:  Jared Klarquist; Zhenyuan Zhou; Nan Shen; Edith M Janssen
Journal:  Mediators Inflamm       Date:  2016-03-30       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.